Healthcare -
Biotechnology - NASDAQ - US
$ 2.58
6.17 %
$ 74.5 M
Market Cap
-0.86
P/E
AVTE - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative AVTE - Aerovate Therapeutics, Inc.
17.2 M
LAST VALUE
46.27%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR